Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avtar Dhillon Insider Profile
4 Followers
Avtar Dhillon, Director at Inovio Pharmaceuticals, holds 62.05K shares in OncoSec Medical (Ticker: ONCSQ), holds 106.00K shares in Inovio Pharmaceuticals (Ticker: INO), holds 8.52M shares in Arch Therapeutics (Ticker: ARTH).
Avtar Dhillon has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Avtar Dhillon holds in companies
Most Profitable Insider Trade
The most profitable trade made by Avtar Dhillon
Avtar Dhillon's Trading History
Inovio Pharmaceuticals
Dec 06, 2018
Director
Uninformative Buy
50.00K
$1.07M
Arch Therapeutics
Jul 20, 2018
Director
Uninformative Buy
―
$7.92M
OncoSec Medical
Apr 21, 2020
Director
Uninformative Buy
19.38K
$1.80K
List of latest transactions for each holding click on a transaction to see Avtar Dhillon's performance on stock
You May Also Like
Avtar Dhillon insider profile FAQ
What is the percentage of profitable transactions made by Avtar Dhillon?
The percentage of profitable transactions made by Avtar Dhillon is ―.
What is the average return per transaction made by Avtar Dhillon?
The average return per transaction made by Avtar Dhillon is ―.
What stocks does Avtar Dhillon hold?
Avtar Dhillon holds: INO, ARTH, ONCSQ stocks.
What was Avtar Dhillon’s latest transaction?
Avtar Dhillon latest transaction was an Uninformative Buy of $19.38K.
What was Avtar Dhillon's most profitable transaction?
Avtar Dhillon’s most profitable transaction was an Informative Buy of ONCSQ stock on October 16, 2015. The return on the trade was -58.00%.
What is Avtar Dhillon's role in Inovio Pharmaceuticals?
Avtar Dhillon's role in Inovio Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.